Become a subscriber
Newsroom
Arjo’s product range is now MDR and UKCA certified
Arjo has received its final Medical Device Regulation (MDR) and UKCA certificates for the EU and the United Kingdom respectively. Maintaining safe and high-quality products permeates all of Arjo’s development activities and remains constantly high on the Group’s agenda, with a clear connection to both customer value and business performance.
Arjo launches ESG index to gear up transparency and disclosure
Being a highly trusted company is key to Arjo’s continued growth and success. With the increased transparency of a new index presenting Arjo’s positions, policies and statements within the Environmental, Social and Governance (ESG) area, Arjo aims to strengthen its positioning in the ESG and sustainability domain.
Arjo secures renewal of major rental tender in France
Arjo wins the highly esteemed UGAP rental tender in France, securing yet another five years of offering premium rental solutions to healthcare providers across France. The win is also another step in the company’s journey towards driving profitable growth and a proof of Arjo’s position as a trusted partner to healthcare.
Arjo’s interim report January-September 2023
”We are leaving behind a quarter of growth and improved profitability in line with our ambitions, as well as a strong cash flow. Rental and service performed well globally and we are continuing to see signs of a gradual improvement in the US, despite a challenging market situation. With high activity levels, we continue our efforts to strengthen...
Arjo announces date of 2023 Q3 report and conference call
Arjo will issue its interim report for Q3 2023 on Thursday October 19 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO.
Arjo launches the Evenda bed range for long-term care
Today, on World Alzheimer´s Day, Arjo is taking yet another step to help improve life for people who live with dementia and their caregivers by introducing the Evenda bed.
Arjo shares insights to advance the field of pressure injury prevention
Early detection and efficient prevention are areas in which Arjo is contributing to advancing the field of pressure injury prevention and improving patient outcomes. This month Arjo is presenting research and field insights at the European Pressure Ulcer Advisory Panel annual meeting in Leeds, UK.
Arjo’s interim report January-June 2023
”The recovery following a turbulent 2022 continues and we grew 5% organically with improved profitability and strong cash flow. Demand was healthy in many markets and despite continuing challenging market conditions in the US, we expect to deliver organic growth for the full-year within our target interval of 3–5%,” says Joacim Lindoff, President...
Arjo announces date of 2023 Q2 report and conference call
Arjo will issue its interim report for Q2 2023 on Friday July 14 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO.
Niclas Sjöswärd appointed new CFO at Arjo
Niclas Sjöswärd has been appointed new CFO at Arjo. Niclas most recently comes from the role of Vice President Corporate Control at Getinge, and his previous positions include CFO of Getinge’s Acute Care Therapies business area. Niclas will take office as CFO and member of Arjo’s Management Team in mid-October 2023.
Daniel Fäldt leaving his position as CFO at Arjo
Arjo’s CFO Daniel Fäldt has due to family reasons decided to leave his position as CFO and member of the Arjo Management team with immediate effect.
Resolutions at Arjo’s Annual General Meeting 20 April 2023
Arjo AB (publ) held the 2023 Annual General Meeting on Thursday 20 April. At the Annual General Meeting the following was resolved:
Arjo’s interim report January-March 2023
”The Group grew organically by 4.3%, giving us a stable start to the year. Demand for Arjo’s products and solutions was high, and despite a volatile market we remain confident that we will reach the target of 3–5% organic growth for the full-year,” says Joacim Lindoff, President and CEO of Arjo.
Arjo announces date of 2023 Q1 report and conference call
Arjo will issue its interim report for Q1 2023 on Thursday April 20 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.
Arjo publishes its Annual and Sustainability Report for 2022
Arjo’s Annual and Sustainability Report for 2022 is now available on the Group’s website.
NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB (PUBL)
The shareholders of Arjo AB (publ), Corporate ID No. 559092-8064, are hereby invited to attend the Annual General Meeting (the “AGM”) on Thursday, 20 April 2023 at 11.00 a.m. CEST, at Glasklart, Dockplatsen 1, Malmö, Sweden.
Arjo’s year-end report January-December 2022
”We close a year in which growth was primarily held back by lower critical care rental volumes in the US compared with 2021. Adjusted for this the Group grew organically by approximately 3% in 2022, which demonstrates the strength of our underlying business. During the fourth quarter, growth continued across all major markets outside the US, and we...
Arjo announces date for 2022 year-end report and conference call
Arjo will issue its year-end report for 2022 on Wednesday January 25 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.